The aim of the study protocol is to measure product-specific COVID-19 vaccine effectiveness to prevent transmission of SARS-CoV-2 infection from healthcare workers to their contacts, which can be either other patients or healthcare workers, in healthcare settings.
Human medicines European public assessment report (EPAR): Livtencity, maribavir, Cytomegalovirus Infections, Date of authorisation: 09/11/2022, Revision: 4, Status: Authorised
Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief.